All In MedTech

FDA Clearance Tracker · P190006-S025

Axonics Sacral Neuromodulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 11, 2021

Approved

Time to decision

219 days

Received Nov 4, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190006-S025
Device name
Axonics Sacral Neuromodulation System
Applicant location
Marlborough, MA
Received
Nov 4, 2020
Decided
Jun 11, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P190006

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

Approval for the addition of "3T RF whole-body coil conditional MRI scans at MC 2 mode" labeling on the Axonics Sacral Neuromodulation System.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.